home All News open_in_new Full Article

Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL

Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL  Stock Titan


today 6 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Transport
attach_file Politics
attach_file Politics
attach_file Events
attach_file Transport
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1048732972
Add Watch Country

arrow_drop_down